Dana Investment Advisors, Inc. - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 2 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Dana Investment Advisors, Inc. ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$315,730
-5.0%
15,409
-7.9%
0.02%0.0%
Q2 2023$332,306
+22.8%
16,724
+5.9%
0.02%
+14.3%
Q1 2023$270,534
-3.8%
15,793
+9.9%
0.01%
-6.7%
Q4 2022$281,28014,3730.02%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 665,880$10,627,00011.09%
RTW INVESTMENTS, LP 15,802,802$252,213,0005.82%
Ally Bridge Group (NY) LLC 479,506$7,653,0005.05%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,204,0002.48%
TIGER MANAGEMENT L.L.C. 279,700$4,464,0001.95%
Prosight Management, LP 200,000$3,192,0001.71%
COWEN AND COMPANY, LLC 999,588$15,953,0001.53%
Boxer Capital, LLC 1,466,051$23,398,0001.32%
Affinity Asset Advisors, LLC 267,794$4,274,0001.19%
HARBOR CAPITAL ADVISORS, INC. 66,410$1,060,0000.97%
View complete list of ROCKET PHARMACEUTICALS INC shareholders